Previous close | 2,220.20 |
Open | 2,165.00 |
Bid | 2,026.10 x 49400 |
Ask | 2,172.50 x 13500 |
Day's range | 2,165.00 - 2,165.00 |
52-week range | 1,725.90 - 2,252.70 |
Volume | |
Avg. volume | 1,673 |
Market cap | 5.484T |
Beta (5Y monthly) | 0.40 |
PE ratio (TTM) | 141.32 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 51.09 (2.30%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
RAHWAY, N.J., May 01, 2024--Merck Announces KEYNOTE-811 Trial Met Dual Primary Endpoint as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or GEJ Cancer
RAHWAY, N.J., April 29, 2024--Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
RAHWAY, N.J., April 25, 2024--Merck Announces First-Quarter 2024 Financial Results